Frontlight ResearchEarly access
Trial site
Re:Cognition Health - Guildford
- 5running trials
- 1closed trial
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease6 trials
- Mild cognitive impairment1 trial
- Phase
- Phase 23 trials
- Phase 33 trials
- Status
- Active, not recruiting5 trials
- Completed1 trial
- Lead sponsor
- Eli Lilly and Company3 trials
- Acumen Pharmaceuticals1 trial
- Alector Inc.1 trial
- Janssen Pharmaceutica N.V., Belgium1 trial
Running trials
Active, not recruiting
A Study of JNJ-64042056 in Participants With Preclinical Alzheimer's Disease
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)
Closed trials
Site data: ClinicalTrials.govUpdated 15 Nov 2026